Key Symptom Domains to Be Assessed in Fibromyalgia (Outcome Measures in Rheumatoid Arthritis Clinical Trials)

被引：27
|
作者：
Choy, Ernest H. [1 ]
Mease, Philip J. [2 ,3 ]
机构：
[1] Kings Coll London, Weston Educ Ctr, Acad Dept Rheumatol, Sir Alfred Baring Garrod Clin Trials Unit, London SE5 9RJ, England
[2] Swedish Med Ctr, Div Rheumatol Res, Seattle, WA 98104 USA
[3] Univ Washington, Seattle, WA 98104 USA
来源：
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2009年 / 35卷 / 02期
关键词：
Fibromyalgia; Domains; Core data set; Assessment; Clinical trials; PAIN; PREVALENCE; DIAGNOSIS; CRITERIA; IMPACT;
D O I：
10.1016/j.rdc.2009.05.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This article discusses the key symptom domains to be assessed in fibromyalgia. Development of a consensus on a core set of outcome measures that should be assessed and reported in all clinical trials is needed to facilitate interpretation, pooling, and comparison of results. This aligns with the key objective of the Outcome Measures in Rheumatoid Arthritis Clinical Trials initiative to improve outcome measurement in rheumatic diseases through a data-driven interactive consensus process.
引用
下载
收藏
页码：329 / +
页数：10
相关论文
共 50 条
  • [31] FIBROMYALGIA: KEY CLINICAL DOMAINS, COMORBIDITIES, ASSESSMENT, AND TREATMENT
    Mease, Philip J.
    CNS SPECTRUMS, 2009, 14 (12) : 6 - 9
  • [32] THE RESPONSIVENESS OF OUTCOME MEASURES IN RHEUMATOID-ARTHRITIS
    BUCHBINDER, R
    BOMBARDIER, C
    YEUNG, M
    TUGWELL, P
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S295 - S295
  • [33] SENSITIVITY TO CHANGE OF RHEUMATOID-ARTHRITIS CLINICAL-TRIAL OUTCOME MEASURES
    ANDERSON, JJ
    CHERNOFF, MC
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (03) : 535 - 537
  • [34] Outcome measures for intervention trials in somatic symptom disorders
    Burton, C.
    Chowdhury, S.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2016, 85 : 58 - 59
  • [35] COULD ENHANCED PATIENT EDUCATION IMPROVE THE OUTCOME OF CLINICAL TRIALS IN RHEUMATOID ARTHRITIS?
    Cseuz, R. M.
    Megyaszai, M.
    Shenker, B.
    Mirzahosseini, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1267 - 1268
  • [36] Measuring outcome in rheumatoid arthritis - Which measures are suitable for routine clinical use?
    Blake, DR
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (03): : 301 - 301
  • [37] Clinical trials on biologics in rheumatoid arthritis
    Sander, O
    Rau, R
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1998, 36 (11) : 621 - 624
  • [38] Core Symptom Measures in Cancer Clinical Trials
    Gotay, Carolyn
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (07):
  • [39] Trials in rheumatoid arthritis:: choosing the right outcome measures -: comment on the article by Felson et al
    Porter, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (09) : 1356 - 1356
  • [40] MRI of Rheumatoid Arthritis: Comparing the Outcome Measures in Rheumatology Clinical Trials (OMERACT) Scoring and Volume of Synovitis for the Assessment of Biologic Therapy
    Nakahara, Ryuichi
    Nishida, Keiichiro
    Hashizume, Kenzo
    Harada, Ryouzou
    Machida, Takahiro
    Horita, Masahiro
    Ohtsuka, Aiji
    Ozaki, Toshifumi
    ACTA MEDICA OKAYAMA, 2015, 69 (01) : 29 - 35
12345